Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Interventional × Myositis × Clear all

Phase

Status

Recruiting 2 Completed 1

Sponsor Class

Study Type

Observational 3 Interventional 1

Sponsor

Conditions

Breast Neoplasms 4353 Neoplasms 3623 Prostatic Neoplasms 2111 Carcinoma, Non-Small-Cell Lung 1929 Colorectal Neoplasms 1789 Lung Neoplasms 1486 Multiple Myeloma 1254 Lymphoma 1233 Neoplasm Metastasis 1204 Leukemia, Myeloid, Acute 1189 Melanoma 1104 Pancreatic Neoplasms 1049 Leukemia 1048 Ovarian Neoplasms 1033 Lymphoma, Non-Hodgkin 966 Precursor Cell Lymphoblastic Leukemia-Lymphoma 928 Head and Neck Neoplasms 912 Leukemia, Lymphocytic, Chronic, B-Cell 847 Brain Neoplasms 787 Colonic Neoplasms 771 Lymphoma, Follicular 763 Stomach Neoplasms 745 Glioblastoma 739 Carcinoma, Hepatocellular 732 Recurrence 731 Rectal Neoplasms 664 Lymphoma, Large B-Cell, Diffuse 655 Uterine Cervical Neoplasms 630 Carcinoma, Renal Cell 611 Hodgkin Disease 601

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00774462 2012-12-11

FORCE

Assistance Publique - Hôpitaux de Paris

Phase 2 Completed

Myasthenia Gravis, Myositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡